WallStSmart
BNR

Burning Rock Biotech Ltd

NASDAQ: BNR · HEALTHCARE · DIAGNOSTICS & RESEARCH

$16.83
+0.55% today

Updated 2026-06-05

Market cap
$96.61M
P/E ratio
P/S ratio
0.18x
EPS (TTM)
$-0.77
Dividend yield
52W range
$3 – $42
Volume
0.0M

Burning Rock Biotech Ltd (BNR) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201720182019202020212022202320242025
Total assets$400.33M$372.67M$847.56M$2.66B$2.28B$1.59B$1.04B$885.30M$820.90M
Cash & equivalents$54.79M$93.34M$94.23M$1.90B$1.43B$905.45M$615.10M$519.85M$481.39M
Current assets$298.93M$292.99M$706.79M$2.52B$1.82B$1.26B$884.10M$776.62M$739.06M
Total liabilities$231.85M$976.14M$1.74B$242.02M$433.28M$429.13M$271.59M$304.48M$285.29M
Current liabilities$78.06M$284.70M$164.44M$241.53M$372.18M$411.45M$263.36M$266.30M$247.14M
Long-term debt$87.64M$18.27M$1.70M
Shareholder equity$168.49M$-603.46M$-891.49M$2.42B$1.85B$1.16B$768.41M$580.83M$535.60M
Retained earnings$-379.52M$-612.00M$-946.46M$-1.42B$-2.23B$-3.20B$-3.85B$-4.20B$-4.26B
Accounts receivable$41.23M$35.52M$89.73M$110.75M$161.43M$170.23M$149.61M$173.45M$182.03M
Inventory$16.80M$49.05M$58.12M$68.02M$123.21M$130.32M$69.02M$53.76M$57.01M
Goodwill$1.82M$284179.00

Frequently asked questions

What is Burning Rock Biotech Ltd's revenue?

Burning Rock Biotech Ltd's trailing twelve-month revenue is $539.57M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is BNR?

In its most recent fiscal year, BNR ran a gross margin of 74.67%, an operating margin of -10.16%, and a net margin of -10.26%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does BNR generate?

BNR produced $-33.69M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BNR's balance sheet healthy?

BNR holds $481.39M in cash and equivalents against $1.70M in long-term debt, on $535.60M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.